Literature DB >> 15123069

Microbial-gut interactions in health and disease. Immune responses.

Karen M Pickard1, A Ronald Bremner, John N Gordon, Thomas T MacDonald.   

Abstract

The indigenous bacterial microflora colonize the gut at birth and remain there throughout life. Approximately 10(14) bacteria are present in the ileum and colon and they are clearly immunogenic. The evidence is strong that the vast majority of IgA plasma cells in normal human gut are responding to the antigens of the flora, and although the flora is also responsible for producing the large numbers of T cells which are present in the gut of healthy individuals, the types of T cell response which the flora elicits are less well understood. A major challenge for the immune system is to distinguish between the antigens of the flora and the antigens of pathogens. There is also a growing realization that the normal flora can also influence gene expression in antigen-presenting cells in the gut and so set the context in which T cells respond to food antigen and vaccines.

Entities:  

Mesh:

Year:  2004        PMID: 15123069     DOI: 10.1016/j.bpg.2003.10.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  11 in total

Review 1.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

2.  Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.

Authors:  Daniela Poppe; Imke Tiede; Gerhard Fritz; Christoph Becker; Brigitte Bartsch; Stefan Wirtz; Dennis Strand; Shinya Tanaka; Peter R Galle; Xosé R Bustelo; Markus F Neurath
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

3.  Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide.

Authors:  Randal Eckert; Jian He; Daniel K Yarbrough; Fengxia Qi; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

4.  Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.

Authors:  Ilaria Peluso; Daniele Fina; Roberta Caruso; Carmine Stolfi; Flavio Caprioli; Massimo Claudio Fantini; Giorgio Caspani; Enzo Grossi; Laura Di Iorio; Francesco Maria Paone; Francesco Pallone; Giovanni Monteleone
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

5.  Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp.

Authors:  Randal Eckert; Fengxia Qi; Daniel K Yarbrough; Jian He; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 6.  MicroRNAs in mucosal inflammation.

Authors:  Viola Neudecker; Xiaoyi Yuan; Jessica L Bowser; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-07-20       Impact factor: 4.599

7.  Probiotics and prebiotics for gastrointestinal infections.

Authors:  Joshua Novak; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

8.  CARD15 status and familial predisposition for Crohn's disease and colonic gene expression.

Authors:  Claudio Csillag; Ole Haagen Nielsen; Rehannah Borup; Jørgen Olsen; Jacob Tveiten Bjerrum; Finn Cilius Nielsen
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 9.  Gut microbiota and inflammation.

Authors:  Asa Hakansson; Goran Molin
Journal:  Nutrients       Date:  2011-06-03       Impact factor: 5.717

Review 10.  Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.

Authors:  Duk Hwan Kim; Jae Hee Cheon
Journal:  Immune Netw       Date:  2017-02-23       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.